• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化住院患者的下腰痛:一项回顾性研究。

Low back pain in patients hospitalised with liver cirrhosis- a retrospective study.

机构信息

Department of Physiatry, Balneology and Rehabilitation of the Slovak Medical University, F. D. Roosevelt Teaching Hospital, Banská Bystrica, Slovakia.

Faculty of Arts, Department of Physical Education and Sports, Matej Bel University, Tajovského 40, Banská Bystrica, 974 01, Slovakia.

出版信息

BMC Musculoskelet Disord. 2023 Apr 19;24(1):310. doi: 10.1186/s12891-023-06424-8.

DOI:10.1186/s12891-023-06424-8
PMID:37076822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10114370/
Abstract

BACKGROUND

Lower back pain is a common issue, but little is known about the prevalence of pain in patients with liver cirrhosis during hospitalisation. Therefore, the objective of this study was to determine lower back pain in patients with liver cirrhosis.

METHODS

The sample consisted of patients with liver cirrhosis (n = 79; men n = 55; women n = 24; mean age = 55.79 ± 12.52 years). The hospitalised patients were mobile. The presence and intensity of pain were assessed in the lumbar spine during hospitalisation. The presence of pain was assessed using the visual analogue pain scale (0-10). The range of motion of the lower spine was assessed using the Schober and Stibor tests. Frailty was measured by Liver Frailty Index (LFI). The condition of liver disease was evaluated using The Model For the End-Stage Liver Disease (MELD) and Child-Pugh score (CPS) and ascites classification. Student's t test and Mann-Whitney test were used for analysis of the difference of group. Analysis of variance (ANOVA) with the Tukey post hoc test was used to test differences between categories of liver frailty index. The Kruskal-Wallis test was used to test pain distribution. Statistical significance was determined at the α-0.05 significance level.

RESULT

The prevalence of pain in patients with liver cirrhosis was 13.92% (n = 11), and the mean intensity of pain according to the visual analogue scale was 3.73 (± 1.90). Lower back pain was present in patients with ascites (15.91%; n = 7) and without ascites (11.43%; n = 4). The prevalence of lower back pain was not statistically significant between patients with and without ascites (p = 0,426). The base of Schober's assessment mean score was 3.74 cm (± 1.81), and based on Stibor's assessment mean score was 5.84 cm (± 2.23).

CONCLUSION

Lower back pain in patients with liver cirrhosis is a problem that requires attention. Restricted spinal mobility has been reported in patients with back pain, according to Stibor, compared to patients without pain. There was no difference in the incidence of pain in patients with and without ascites.

摘要

背景

下腰痛是一种常见问题,但关于肝硬化患者住院期间疼痛的发生率知之甚少。因此,本研究旨在确定肝硬化患者的下腰痛情况。

方法

样本包括 79 例肝硬化患者(男性 55 例,女性 24 例;平均年龄 55.79 ± 12.52 岁)。住院患者可移动。在住院期间评估腰椎的疼痛存在和强度。使用视觉模拟疼痛量表(0-10)评估疼痛的存在。使用 Schober 和 Stibor 测试评估下脊柱的活动范围。使用肝脏脆弱指数(LFI)测量脆弱性。使用终末期肝病模型(MELD)和 Child-Pugh 评分(CPS)和腹水分类评估肝病状况。采用 Student's t 检验和 Mann-Whitney 检验分析组间差异。采用方差分析(ANOVA)和 Tukey 事后检验测试肝脏脆弱指数类别之间的差异。采用 Kruskal-Wallis 检验测试疼痛分布。以α-0.05 显著性水平确定统计学意义。

结果

肝硬化患者疼痛的发生率为 13.92%(n=11),视觉模拟量表评估的疼痛平均强度为 3.73(±1.90)。有腹水的患者(15.91%;n=7)和无腹水的患者(11.43%;n=4)均存在下腰痛。有腹水和无腹水的患者的下腰痛发生率无统计学差异(p=0.426)。Schober 评估的平均基线分数为 3.74cm(±1.81),Stibor 评估的平均基线分数为 5.84cm(±2.23)。

结论

肝硬化患者的下腰痛是一个需要关注的问题。据 Stibor 报道,有腰痛的患者脊柱活动受限,而无腰痛的患者则没有。有腹水和无腹水的患者疼痛发生率无差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bfa/10114370/8db0ac00afd3/12891_2023_6424_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bfa/10114370/b88f293c11ef/12891_2023_6424_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bfa/10114370/8db0ac00afd3/12891_2023_6424_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bfa/10114370/b88f293c11ef/12891_2023_6424_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bfa/10114370/8db0ac00afd3/12891_2023_6424_Fig2_HTML.jpg

相似文献

1
Low back pain in patients hospitalised with liver cirrhosis- a retrospective study.肝硬化住院患者的下腰痛:一项回顾性研究。
BMC Musculoskelet Disord. 2023 Apr 19;24(1):310. doi: 10.1186/s12891-023-06424-8.
2
The Refit model for end-stage liver disease-Na is not a better predictor of mortality than the Refit model for end-stage liver disease in patients with cirrhosis and ascites.终末期肝病钠模型(Refit model for end-stage liver disease-Na)并不优于终末期肝病模型(Refit model for end-stage liver disease)预测肝硬化伴腹水患者的死亡率。
Clin Mol Hepatol. 2014 Mar;20(1):47-55. doi: 10.3350/cmh.2014.20.1.47. Epub 2014 Mar 26.
3
Pro-Brain Natriuretic Peptide and Troponin T-Hypersensitivity Levels Correlate With the Severity of Liver Dysfunction in Liver Cirrhosis.脑钠肽前体和肌钙蛋白T超敏水平与肝硬化患者肝功能障碍的严重程度相关。
Am J Med Sci. 2017 Aug;354(2):131-139. doi: 10.1016/j.amjms.2017.04.005. Epub 2017 Apr 7.
4
Assessing the risk of decompensation by ascites and spontaneous bacterial peritonitis in cirrhosis.评估肝硬化患者腹水及自发性细菌性腹膜炎导致失代偿的风险。
Rev Med Chir Soc Med Nat Iasi. 2014 Apr-Jun;118(2):320-6.
5
Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease ≥15.肝硬化且终末期肝病模型评分≥15分患者的经颈静脉肝内门体分流术
Dig Dis Sci. 2017 Feb;62(2):534-542. doi: 10.1007/s10620-016-4185-3. Epub 2016 May 6.
6
The influence of prehabilitation in patients with liver cirrhosis before liver transplantation: a randomized clinical trial.肝移植前肝硬化患者的预康复治疗的影响:一项随机临床试验。
Eur J Phys Rehabil Med. 2024 Feb;60(1):122-129. doi: 10.23736/S1973-9087.23.08130-3. Epub 2023 Dec 7.
7
Prognostic value of the third lumbar skeletal muscle mass index in patients with liver cirrhosis and ascites.肝硬化伴腹水患者第三腰椎骨骼肌指数的预后价值。
Clin Nutr. 2020 Jun;39(6):1908-1913. doi: 10.1016/j.clnu.2019.08.006. Epub 2019 Aug 15.
8
Frailty as Tested by Gait Speed is an Independent Risk Factor for Cirrhosis Complications that Require Hospitalization.通过步速测试的衰弱是肝硬化并发症需住院治疗的独立危险因素。
Am J Gastroenterol. 2016 Dec;111(12):1768-1775. doi: 10.1038/ajg.2016.336. Epub 2016 Aug 30.
9
The model for the end-stage liver disease and Child-Pugh score in predicting prognosis in patients with liver cirrhosis and esophageal variceal bleeding.终末期肝病模型及Child-Pugh评分在预测肝硬化合并食管静脉曲张出血患者预后中的应用
Vojnosanit Pregl. 2009 Sep;66(9):724-8. doi: 10.2298/vsp0909724b.
10
Frailty is associated with increased risk of cirrhosis disease progression and death.衰弱与肝硬化疾病进展和死亡的风险增加有关。
Hepatology. 2022 Mar;75(3):600-609. doi: 10.1002/hep.32157. Epub 2021 Dec 5.

引用本文的文献

1
Relationship between Spinal Range of Motion and Functional Tests in University Students: The Role of Demographic Factors.大学生脊柱活动范围与功能测试之间的关系:人口统计学因素的作用
Healthcare (Basel). 2024 May 16;12(10):1029. doi: 10.3390/healthcare12101029.
2
Muscle Strength and Joint Range of Motion of the Spine and Lower Extremities in Female Prepubertal Elite Rhythmic and Artistic Gymnasts.青春期前女性优秀艺术体操和竞技体操运动员脊柱及下肢的肌肉力量和关节活动范围
J Funct Morphol Kinesiol. 2023 Nov 2;8(4):153. doi: 10.3390/jfmk8040153.

本文引用的文献

1
Effect of Body Mass Index on the Prognosis of Liver Cirrhosis.体重指数对肝硬化预后的影响
Front Nutr. 2021 Aug 20;8:700132. doi: 10.3389/fnut.2021.700132. eCollection 2021.
2
MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.MELD 3.0:适应新时代的终末期肝病模型。
Gastroenterology. 2021 Dec;161(6):1887-1895.e4. doi: 10.1053/j.gastro.2021.08.050. Epub 2021 Sep 3.
3
Back Pain Prevalence, Intensity, and Associated Risk Factors among Female Teachers in Slovakia during the COVID-19 Pandemic: A Cross-Sectional Study.
新冠疫情期间斯洛伐克女性教师背痛的患病率、严重程度及相关危险因素:一项横断面研究
Healthcare (Basel). 2021 Jul 7;9(7):860. doi: 10.3390/healthcare9070860.
4
Applicability and prognostic value of frailty assessment tools among hospitalized patients with advanced chronic liver disease.住院的晚期慢性肝病患者中衰弱评估工具的适用性和预后价值。
Croat Med J. 2021 Feb 28;62(1):8-16. doi: 10.3325/cmj.2021.62.8.
5
Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019.基于 2019 年全球疾病负担研究的全球康复需求估计:2019 年全球疾病负担研究的系统分析。
Lancet. 2021 Dec 19;396(10267):2006-2017. doi: 10.1016/S0140-6736(20)32340-0. Epub 2020 Dec 1.
6
Irisin in Liver Cirrhosis.肝硬化中的鸢尾素
J Clin Med. 2020 Sep 29;9(10):3158. doi: 10.3390/jcm9103158.
7
Exercise and physical activity in cirrhosis: opportunities or perils.肝硬化患者的运动与体力活动:机遇还是风险?
J Appl Physiol (1985). 2020 Jun 1;128(6):1547-1567. doi: 10.1152/japplphysiol.00798.2019. Epub 2020 Apr 2.
8
Optimal management of ascites.腹水的最佳管理
Liver Int. 2020 Feb;40 Suppl 1:128-135. doi: 10.1111/liv.14361.
9
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.2017 年全球疾病负担研究:1990-2017 年 195 个国家和地区按病因划分的肝硬化全球、区域和国家负担:系统分析。
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):245-266. doi: 10.1016/S2468-1253(19)30349-8. Epub 2020 Jan 22.
10
Cirrhosis: Diagnosis and Management.肝硬化:诊断与管理。
Am Fam Physician. 2019 Dec 15;100(12):759-770.